The global Hazardous Drugs Closed System Transfer Device market size was valued at USD 768.4 million in 2022 and is forecast to a readjusted size of USD 2488.5 million by 2029 with a CAGR of 18.3% during review period.
Hazardous Drugs Closed System Transfer Device is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
United States is dominating the global Hazardous Drugs Closed System Transfer Device market. There are four key players are dominating the global market, BD Medical, Equashield, ICU Medical and Teva Medical Ltd, etc. The global top four players have a share over 80 percent.
This report is a detailed and comprehensive analysis for global Hazardous Drugs Closed System Transfer Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hazardous Drugs Closed System Transfer Device market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Hazardous Drugs Closed System Transfer Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Hazardous Drugs Closed System Transfer Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Hazardous Drugs Closed System Transfer Device market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hazardous Drugs Closed System Transfer Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hazardous Drugs Closed System Transfer Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
BD Medical, Inc
Equashield
ICU Medical
Teva Medical Ltd
Corvida Medical
B. Braun
Simplivia Healthcare Ltd.
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Hospital
Clinic
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths
- Increasing regulations and safety protocols around handling hazardous drugs are driving market growth.
- Growing awareness of healthcare worker safety and the need to minimize exposure to toxic drugs enhances product demand.
Weaknesses
- High initial investment costs for hospitals and healthcare systems could limit widespread adoption.
- Limited product awareness in emerging markets, leading to slow market penetration.
Opportunities
- Expansion of the pharmaceutical sector and new drug therapies present opportunities for growth.
- Rising global healthcare infrastructure improvements, especially in developing regions, create new markets for CSTDs.
Threats
- Stringent regulatory approvals and delays in product certification could hinder market expansion.
- Competition from alternative drug delivery systems or non-closed systems may limit market share.
Political
- Increasing government regulations and policies surrounding the safety of healthcare workers are pushing the demand for CSTDs.
- Policies promoting the adoption of advanced safety equipment in healthcare settings may drive market growth.
Economic
- High healthcare costs, particularly in developed nations, may hinder adoption due to the high upfront investment in CSTDs.
- Economic growth in emerging markets offers significant potential for expanding market reach and adoption of CSTDs.
Social
- Growing awareness about the health risks associated with hazardous drug exposure is driving demand for safer handling solutions.
- The aging global population and increasing cancer rates contribute to a rising need for safer drug transfer devices.
Technological
- Advancements in closed system technology, making CSTDs more efficient and cost-effective, may stimulate market growth.
- Increased research and development in alternative drug delivery methods could pose competition to CSTDs.
Environmental
- Growing environmental concerns related to hazardous waste disposal may push for more sustainable and eco-friendly CSTDs.
- Regulations on the environmental impact of pharmaceutical waste could drive innovation in safer and greener drug transfer solutions.
Legal
- Stringent regulatory requirements for medical devices, such as CSTDs, create challenges for manufacturers but ensure product safety.
- Lawsuits related to healthcare worker safety and negligence could lead to more stringent regulations, driving demand for closed system devices.
Suppliers
- Manufacturers of medical devices and pharmaceutical companies that produce hazardous drugs provide key inputs to the market.
- Regulatory bodies that establish safety standards influence the design and production of CSTDs.
Inputs
- Raw materials such as plastics, rubbers, and other biocompatible materials are essential for device manufacturing.
- Research and development data on hazardous drug handling, as well as compliance with safety protocols, are vital inputs.
Processes
- The design and manufacturing process for CSTDs involves ensuring device safety, quality, and compliance with regulations.
- Testing and validation of CSTDs through clinical trials and simulations to meet healthcare standards and effectiveness.
Outputs
- Closed system transfer devices that ensure safe handling and transfer of hazardous drugs without exposure risks.
- Market-ready products that are distributed to healthcare facilities, hospitals, and pharmacies.
Customers
- Healthcare providers, including hospitals and clinics, that need safe drug handling solutions for chemotherapy and other hazardous drugs.
- Pharmaceutical companies and manufacturers who use CSTDs in their drug production and packaging processes.
Threat of New Entrants
- High capital investment and stringent regulatory requirements act as barriers to entry for new players in the CSTDs market.
- However, technological advancements and potential market growth opportunities could encourage new competitors to enter the market.
Bargaining Power of Suppliers
- Limited suppliers of specialized materials and components for CSTDs may give suppliers significant bargaining power.
- However, as the market expands, more suppliers may emerge, potentially reducing supplier power.
Bargaining Power of Buyers
- Healthcare providers and large pharmaceutical companies have considerable bargaining power due to their purchasing volumes.
- However, with increasing regulations and safety concerns, buyers may be more willing to accept higher costs for improved safety and compliance.
Threat of Substitute Products
- Alternative drug handling and delivery methods, such as non-closed systems or automated drug delivery devices, pose a moderate threat.
- However, the unique safety benefits of CSTDs in hazardous drug handling reduce the likelihood of full substitution.
Industry Rivalry
- The market is competitive, with established players like Becton Dickinson, Baxter, and Corning offering advanced CSTDs.
- Intense competition, especially among top-tier manufacturers, drives innovation and improves product offerings.
Raw Materials
- The production of CSTDs requires specialized materials such as high-quality plastics, rubbers, and medical-grade metals, sourced from specific suppliers.
- The cost and availability of raw materials, particularly biocompatible and durable components, impact production timelines and pricing.
Manufacturing Capabilities
- High-quality manufacturing processes are crucial for ensuring the safety, reliability, and compliance of CSTDs with healthcare standards.
- Manufacturers must invest in advanced technologies and facilities to meet stringent regulatory standards for device production.
Research and Development
- Ongoing R&D is essential for innovating CSTDs that offer better safety features, cost-efficiency, and improved functionality for healthcare settings.
- Collaborations with research institutions and pharmaceutical companies help enhance device design and usability, particularly for emerging therapies.
Regulatory Compliance
- Regulatory bodies, such as the FDA and EMA, set stringent guidelines for CSTDs, influencing product design and approval processes.
- Manufacturers need to navigate complex approval pathways, which can impact the speed of market entry and overall cost structure.
Production
- The production of CSTDs involves specialized manufacturing processes that ensure product safety, durability, and compliance with medical standards.
- Production capacity and efficiency are critical for meeting market demand, especially as healthcare facilities globally prioritize safety and regulatory compliance.
Quality Control and Testing
- Rigorous quality control processes, including clinical testing and validation, are essential to ensure CSTDs perform effectively under real-world conditions.
- Manufacturers must maintain stringent testing protocols to meet regulatory requirements and ensure the safety of healthcare workers handling hazardous drugs.
Supply Chain and Distribution
- Efficient supply chain management is vital for ensuring timely delivery of CSTDs to hospitals, clinics, and pharmacies, especially in response to increasing global demand.
- Distribution networks must navigate complex international regulatory environments to ensure the smooth movement of CSTDs to various regions.
Customer Support and Training
- Providing support services, including training for healthcare professionals on how to use CSTDs effectively, enhances customer satisfaction and adoption rates.
- Manufacturers are increasingly offering maintenance and post-purchase services to build long-term relationships with healthcare providers.
End-User Adoption
- Healthcare providers, including hospitals and oncology clinics, are increasingly adopting CSTDs due to rising awareness about hazardous drug exposure risks.
- The need for compliance with occupational safety regulations and healthcare standards accelerates the adoption of CSTDs in patient care settings.
Market Demand and Growth
- The growing global demand for safe drug handling, particularly in oncology, fuels the market for CSTDs, with significant opportunities in both developed and emerging markets.
- As healthcare systems expand and more healthcare workers are trained on safety protocols, the overall demand for CSTDs is expected to increase, driving market growth.
Regulatory Influence
- Regulatory bodies continue to enforce stricter guidelines on hazardous drug handling, further pushing the need for compliant and reliable CSTDs.
- Ongoing changes in safety standards and compliance regulations influence the design and development of CSTDs to meet evolving requirements.
Customer Education and Awareness
- Effective marketing and educational campaigns about the safety benefits of CSTDs are essential to drive end-user awareness and adoption.
- As healthcare organizations prioritize worker safety, educating customers on the long-term cost benefits of CSTDs is key to sustaining demand.
Chapter 1, to describe Hazardous Drugs Closed System Transfer Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hazardous Drugs Closed System Transfer Device, with price, sales, revenue and global market share of Hazardous Drugs Closed System Transfer Device from 2018 to 2023.
Chapter 3, the Hazardous Drugs Closed System Transfer Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hazardous Drugs Closed System Transfer Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hazardous Drugs Closed System Transfer Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hazardous Drugs Closed System Transfer Device.
Chapter 14 and 15, to describe Hazardous Drugs Closed System Transfer Device sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Hazardous Drugs Closed System Transfer Device
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Closed Vial Access Devices
1.3.3 Closed Syringe Safety Devices
1.3.4 Closed Bag/Line Access Devices
1.4 Market Analysis by Application
1.4.1 Overview: Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Hazardous Drugs Closed System Transfer Device Market Size & Forecast
1.5.1 Global Hazardous Drugs Closed System Transfer Device Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hazardous Drugs Closed System Transfer Device Sales Quantity (2018-2029)
1.5.3 Global Hazardous Drugs Closed System Transfer Device Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BD Medical, Inc
2.1.1 BD Medical, Inc Details
2.1.2 BD Medical, Inc Major Business
2.1.3 BD Medical, Inc Hazardous Drugs Closed System Transfer Device Product and Services
2.1.4 BD Medical, Inc Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Medical, Inc Recent Developments/Updates
2.2 Equashield
2.2.1 Equashield Details
2.2.2 Equashield Major Business
2.2.3 Equashield Hazardous Drugs Closed System Transfer Device Product and Services
2.2.4 Equashield Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Equashield Recent Developments/Updates
2.3 ICU Medical
2.3.1 ICU Medical Details
2.3.2 ICU Medical Major Business
2.3.3 ICU Medical Hazardous Drugs Closed System Transfer Device Product and Services
2.3.4 ICU Medical Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ICU Medical Recent Developments/Updates
2.4 Teva Medical Ltd
2.4.1 Teva Medical Ltd Details
2.4.2 Teva Medical Ltd Major Business
2.4.3 Teva Medical Ltd Hazardous Drugs Closed System Transfer Device Product and Services
2.4.4 Teva Medical Ltd Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Medical Ltd Recent Developments/Updates
2.5 Corvida Medical
2.5.1 Corvida Medical Details
2.5.2 Corvida Medical Major Business
2.5.3 Corvida Medical Hazardous Drugs Closed System Transfer Device Product and Services
2.5.4 Corvida Medical Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Corvida Medical Recent Developments/Updates
2.6 B. Braun
2.6.1 B. Braun Details
2.6.2 B. Braun Major Business
2.6.3 B. Braun Hazardous Drugs Closed System Transfer Device Product and Services
2.6.4 B. Braun Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 B. Braun Recent Developments/Updates
2.7 Simplivia Healthcare Ltd.
2.7.1 Simplivia Healthcare Ltd. Details
2.7.2 Simplivia Healthcare Ltd. Major Business
2.7.3 Simplivia Healthcare Ltd. Hazardous Drugs Closed System Transfer Device Product and Services
2.7.4 Simplivia Healthcare Ltd. Hazardous Drugs Closed System Transfer Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Simplivia Healthcare Ltd. Recent Developments/Updates
3 Competitive Environment: Hazardous Drugs Closed System Transfer Device by Manufacturer
3.1 Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hazardous Drugs Closed System Transfer Device Revenue by Manufacturer (2018-2023)
3.3 Global Hazardous Drugs Closed System Transfer Device Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hazardous Drugs Closed System Transfer Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hazardous Drugs Closed System Transfer Device Manufacturer Market Share in 2022
3.4.2 Top 6 Hazardous Drugs Closed System Transfer Device Manufacturer Market Share in 2022
3.5 Hazardous Drugs Closed System Transfer Device Market: Overall Company Footprint Analysis
3.5.1 Hazardous Drugs Closed System Transfer Device Market: Region Footprint
3.5.2 Hazardous Drugs Closed System Transfer Device Market: Company Product Type Footprint
3.5.3 Hazardous Drugs Closed System Transfer Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hazardous Drugs Closed System Transfer Device Market Size by Region
4.1.1 Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2018-2029)
4.1.2 Global Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2018-2029)
4.1.3 Global Hazardous Drugs Closed System Transfer Device Average Price by Region (2018-2029)
4.2 North America Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029)
4.3 Europe Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029)
4.4 Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029)
4.5 South America Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029)
4.6 Middle East and Africa Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
5.2 Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type (2018-2029)
5.3 Global Hazardous Drugs Closed System Transfer Device Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
6.2 Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application (2018-2029)
6.3 Global Hazardous Drugs Closed System Transfer Device Average Price by Application (2018-2029)
7 North America
7.1 North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
7.2 North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
7.3 North America Hazardous Drugs Closed System Transfer Device Market Size by Country
7.3.1 North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2029)
7.3.2 North America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
8.2 Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
8.3 Europe Hazardous Drugs Closed System Transfer Device Market Size by Country
8.3.1 Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2029)
8.3.2 Europe Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hazardous Drugs Closed System Transfer Device Market Size by Region
9.3.1 Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
10.2 South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
10.3 South America Hazardous Drugs Closed System Transfer Device Market Size by Country
10.3.1 South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2029)
10.3.2 South America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hazardous Drugs Closed System Transfer Device Market Size by Country
11.3.1 Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hazardous Drugs Closed System Transfer Device Market Drivers
12.2 Hazardous Drugs Closed System Transfer Device Market Restraints
12.3 Hazardous Drugs Closed System Transfer Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hazardous Drugs Closed System Transfer Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hazardous Drugs Closed System Transfer Device
13.3 Hazardous Drugs Closed System Transfer Device Production Process
13.4 Hazardous Drugs Closed System Transfer Device Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hazardous Drugs Closed System Transfer Device Typical Distributors
14.3 Hazardous Drugs Closed System Transfer Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BD Medical, Inc Basic Information, Manufacturing Base and Competitors
Table 4. BD Medical, Inc Major Business
Table 5. BD Medical, Inc Hazardous Drugs Closed System Transfer Device Product and Services
Table 6. BD Medical, Inc Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BD Medical, Inc Recent Developments/Updates
Table 8. Equashield Basic Information, Manufacturing Base and Competitors
Table 9. Equashield Major Business
Table 10. Equashield Hazardous Drugs Closed System Transfer Device Product and Services
Table 11. Equashield Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Equashield Recent Developments/Updates
Table 13. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 14. ICU Medical Major Business
Table 15. ICU Medical Hazardous Drugs Closed System Transfer Device Product and Services
Table 16. ICU Medical Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ICU Medical Recent Developments/Updates
Table 18. Teva Medical Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Teva Medical Ltd Major Business
Table 20. Teva Medical Ltd Hazardous Drugs Closed System Transfer Device Product and Services
Table 21. Teva Medical Ltd Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Medical Ltd Recent Developments/Updates
Table 23. Corvida Medical Basic Information, Manufacturing Base and Competitors
Table 24. Corvida Medical Major Business
Table 25. Corvida Medical Hazardous Drugs Closed System Transfer Device Product and Services
Table 26. Corvida Medical Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Corvida Medical Recent Developments/Updates
Table 28. B. Braun Basic Information, Manufacturing Base and Competitors
Table 29. B. Braun Major Business
Table 30. B. Braun Hazardous Drugs Closed System Transfer Device Product and Services
Table 31. B. Braun Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. B. Braun Recent Developments/Updates
Table 33. Simplivia Healthcare Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Simplivia Healthcare Ltd. Major Business
Table 35. Simplivia Healthcare Ltd. Hazardous Drugs Closed System Transfer Device Product and Services
Table 36. Simplivia Healthcare Ltd. Hazardous Drugs Closed System Transfer Device Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Simplivia Healthcare Ltd. Recent Developments/Updates
Table 38. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 39. Global Hazardous Drugs Closed System Transfer Device Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Hazardous Drugs Closed System Transfer Device Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Hazardous Drugs Closed System Transfer Device, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Hazardous Drugs Closed System Transfer Device Production Site of Key Manufacturer
Table 43. Hazardous Drugs Closed System Transfer Device Market: Company Product Type Footprint
Table 44. Hazardous Drugs Closed System Transfer Device Market: Company Product Application Footprint
Table 45. Hazardous Drugs Closed System Transfer Device New Market Entrants and Barriers to Market Entry
Table 46. Hazardous Drugs Closed System Transfer Device Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2018-2023) & (M Units)
Table 48. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2024-2029) & (M Units)
Table 49. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Hazardous Drugs Closed System Transfer Device Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Hazardous Drugs Closed System Transfer Device Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 54. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 55. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Hazardous Drugs Closed System Transfer Device Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Hazardous Drugs Closed System Transfer Device Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 60. Global Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 61. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Hazardous Drugs Closed System Transfer Device Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Hazardous Drugs Closed System Transfer Device Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 66. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 67. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 68. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 69. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2023) & (M Units)
Table 70. North America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2024-2029) & (M Units)
Table 71. North America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 74. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 75. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 76. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 77. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2023) & (M Units)
Table 78. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2024-2029) & (M Units)
Table 79. Europe Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 82. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 83. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 84. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 85. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2018-2023) & (M Units)
Table 86. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2024-2029) & (M Units)
Table 87. Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 90. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 91. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 92. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 93. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2018-2023) & (M Units)
Table 94. South America Hazardous Drugs Closed System Transfer Device Sales Quantity by Country (2024-2029) & (M Units)
Table 95. South America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Hazardous Drugs Closed System Transfer Device Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2018-2023) & (M Units)
Table 98. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Type (2024-2029) & (M Units)
Table 99. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2018-2023) & (M Units)
Table 100. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Application (2024-2029) & (M Units)
Table 101. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2018-2023) & (M Units)
Table 102. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity by Region (2024-2029) & (M Units)
Table 103. Middle East & Africa Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Hazardous Drugs Closed System Transfer Device Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Hazardous Drugs Closed System Transfer Device Raw Material
Table 106. Key Manufacturers of Hazardous Drugs Closed System Transfer Device Raw Materials
Table 107. Hazardous Drugs Closed System Transfer Device Typical Distributors
Table 108. Hazardous Drugs Closed System Transfer Device Typical Customers
List of Figures
Figure 1. Hazardous Drugs Closed System Transfer Device Picture
Figure 2. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Type in 2022
Figure 4. Closed Vial Access Devices Examples
Figure 5. Closed Syringe Safety Devices Examples
Figure 6. Closed Bag/Line Access Devices Examples
Figure 7. Global Hazardous Drugs Closed System Transfer Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Hazardous Drugs Closed System Transfer Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hazardous Drugs Closed System Transfer Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hazardous Drugs Closed System Transfer Device Sales Quantity (2018-2029) & (M Units)
Figure 14. Global Hazardous Drugs Closed System Transfer Device Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hazardous Drugs Closed System Transfer Device by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hazardous Drugs Closed System Transfer Device Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hazardous Drugs Closed System Transfer Device Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hazardous Drugs Closed System Transfer Device Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Hazardous Drugs Closed System Transfer Device Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hazardous Drugs Closed System Transfer Device Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hazardous Drugs Closed System Transfer Device Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hazardous Drugs Closed System Transfer Device Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hazardous Drugs Closed System Transfer Device Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hazardous Drugs Closed System Transfer Device Market Drivers
Figure 74. Hazardous Drugs Closed System Transfer Device Market Restraints
Figure 75. Hazardous Drugs Closed System Transfer Device Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hazardous Drugs Closed System Transfer Device in 2022
Figure 78. Manufacturing Process Analysis of Hazardous Drugs Closed System Transfer Device
Figure 79. Hazardous Drugs Closed System Transfer Device Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
